NCT03750383View on ClinicalTrials.gov

Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 2, 2018

Primary Completion Date

November 17, 2018

Study Completion Date

December 13, 2018

Conditions
RSV Infection
Interventions
DRUG

EDP-938

Subjects will receive EDP-938 once daily on Day 1 and Day 5 (Part 1)

DRUG

EDP-938

Subjects will receive one dose of EDP-938 on Day 1 and Day 8 (Part 2)

DRUG

Cyclosporine

Subjects will receive one dose of cyclosporine on Day 5

DRUG

Prednisone

Subjects will receive prednisone once daily from Day 5 to Day 14

Trial Locations (1)

66219

Pharmaceutical Research Associates, Inc.,, Lenexa

Sponsors
All Listed Sponsors
collaborator

Pharmaceutical Research Associates

OTHER

lead

Enanta Pharmaceuticals, Inc

INDUSTRY